Edition:
United Kingdom

People: Boston Scientific Corp (BSX.N)

BSX.N on New York Stock Exchange

41.86USD
9:00pm BST
Change (% chg)

$-0.59 (-1.39%)
Prev Close
$42.45
Open
$42.57
Day's High
$42.67
Day's Low
$41.83
Volume
1,343,781
Avg. Vol
1,967,708
52-wk High
$43.65
52-wk Low
$31.57

Fitzgerald, Joseph 

Mr. Joseph M. Fitzgerald is Executive Vice President and President - Rhythm Management of the Company. He is our executive vice president and president, Rhythm Management, a position he has held since February 2014, having previously served as senior vice president and president, Cardiac Rhythm Management from July 2011. He served as senior vice president and president, Endovascular from February 2010 until July 2011. Prior to that, Mr. Fitzgerald was president and general manager of Peripheral Interventions and president of Electrophysiology. Mr. Fitzgerald held a variety of management positions in our Neurovascular and Peripheral Interventions businesses. These included numerous regional and divisional sales management assignments up to and including his roles as vice president, Global Marketing for the Neurovascular business and vice president of U.S. Sales for the Neurovascular business. Prior to joining Boston Scientific in 1990 as a sales representative, Mr. Fitzgerald was with Anheuser Busch, Inc., where he held a variety of sales, marketing and training assignments. Mr. Fitzgerald holds a B.S. in Business from Indiana University and an M.B.A. from Southern Illinois University with a concentration in Marketing and Finance.

Basic Compensation

Total Annual Compensation, USD 1,222,380
Restricted Stock Award, USD 1,910,970
Long-Term Incentive Plans, USD --
All Other, USD 902,964
Fiscal Year Total, USD 4,036,320

Options Compensation

  Quantity Market Value
Exercisable -- --
Unexercisable -- --
Exercised 85,227 1,189,630.00
Name Fiscal Year Total

Michael Mahoney

13,970,900

Daniel Brennan

3,665,820

Kevin Ballinger

2,841,490

Joseph Fitzgerald

4,036,320

Edward Mackey

3,818,020

Ian Meredith

--
As Of  31 Dec 2018